The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy

Title
The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy
Authors
Keywords
-
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 116, Issue 2, Pages 303-309
Publisher
Springer Nature
Online
2008-09-22
DOI
10.1007/s10549-008-0183-2

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More